XML 29 R15.htm IDEA: XBRL DOCUMENT

Other Balance Sheet Details

12 Months Ended

Dec. 31, 2022

Other Balance Sheet Details [Abstract]

Inventories consisted of the following:


	December 31,
(in millions)	2022		2021
Raw materials	$	12.0	$	11.2
Work in process	5.6		3.6
Finished goods	17.5		15.7
Total inventories	$	35.1	$	30.5

Property and equipment, net, consisted of the following:


	December 31,
(in millions)	2022		2021
Tenant improvements	$	37.9	$	34.9
Scientific equipment	58.8		51.6
Computer equipment	21.5		18.1
Furniture and fixtures	6.7		5.9
	124.9		110.5
Less accumulated depreciation	(66.3)		(51.9)
Total property and equipment, net	$	58.6	$	58.6

Accounts payable and accrued liabilities consisted of the following:


	December 31,
(in millions)	2022		2021
Accrued employee related costs	$	72.8	$	50.6
Revenue-related reserves for discounts and allowances	131.9		62.7
Accrued development costs	39.1		32.4
Current branded prescription drug fee	27.5		28.6
Accounts payable and other accrued liabilities	76.3		51.5
Total accounts payable and accrued liabilities	$	347.6	$	225.8

The following table presents a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.


	December 31,
(in millions)	2022		2021
Cash and cash equivalents	$	262.9	$	340.8
Restricted cash	7.8		3.2
Total cash, cash equivalents and restricted cash	$	270.7	$	344.0